Type 2 diabetes: Eating this food group may prevent you from developing the condition

TYPE 2 diabetes requires a person to overhaul aspects of their lifestyle to stave off the risk. Fortunately, the disease can be prevented by making certain lifestyle decisions, including eating a popular food group, a study has revealed.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

Abstract: The US industrial revolution led to a significant increase in the amount of dietary sugar consumed annually. The impact has become a public health crisis over the past several decades. The consequences are seen in the dramatic rise in rates of obesity, type 2 diabetes mellitus, and cardiovascular disease.
Source: The Nurse Practitioner - Category: Nursing Tags: Feature: SUGAR CONSUMPTION Source Type: research
The drug, Rybelsus (semaglutide) is the first pill in a class of drugs called glucagon-like peptide (GLP-1) approved for use in the United States. Before Rybelsus, the drug had to be injected.
Source: WebMD Health - Category: Consumer Health News Source Type: news
The panel also recommends approval of Qtrilmet, a fixed-dose combination of metformin hydrochloride/saxagliptin/dapagliflozin for treatment of type 2 diabetes.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Semaglutide is the first oral glucagon-like peptide-1 receptor agonist. Previously, drugs of this class were available only as injectables. The approval is expected to increase uptake.FDA Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news
FDA approves Rybelsus (semaglutide) oral tablets to improve blood sugar in adults with type 2 diabetes, with diet and exercise. It is first GLP-1 receptor protein treatment approved in U.S.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news
FRIDAY, Sept. 20, 2019 -- A new pill to lower blood sugar for people with type 2 diabetes was approved by the U.S. Food and Drug Administration on Friday. The drug, Rybelsus (semaglutide) is the first pill in a class of drugs called glucagon-like...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
TYPE 2 diabetes is a serious condition that affects a person ’s blood sugar levels, and left untreated, serious health complications can occur. One way to control and prevent the condition is to choose the right foods at breakfast.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Conclusions: Under routine care, switching to degludec is dominant, compared with continuing previous basal insulin, in Italian patients with T1D or T2D. PMID: 31526202 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
Find out how the combination of conjugated estrogens and bazedoxifene impacts beta-cell function to improve obesity and in return, reduce the risk for type 2 diabetes.Journal of the Endocrine Society
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Health | Study